Sponsored Sessions

Filters

Filter by Type
Amphitheatre AB
16/06
10:00 - 11:00
Plenary session

Chair: Mariane DE MONTALEMBERT (FRANCE)  

10:00 - 10:30
Progress in Management of Sickle Cell Disease - since the 3rd Global Congress in 2017

( ! ) Notice: Undefined index: url_joomla in /var/www/interactive-programme.europa-organisation.com/current/gcscd2022/class/DisplayProgramme.php on line 195
Call Stack
#TimeMemoryFunctionLocation
10.0005253272{main}( ).../schedule_sponsored.php:0
20.15001788112include( '/var/www/interactive-programme.europa-organisation.com/current/gcscd2022/view/content.php' ).../schedule_sponsored.php:88
30.15651803336DisplayProgramme::getPersonsInfoWithMedia( ).../content.php:585

Alexis THOMPSON (UNITED STATES)

10:30 - 11:00
Roundtable on State of Sickle Cell Disease in Africa and India

( ! ) Notice: Undefined index: url_joomla in /var/www/interactive-programme.europa-organisation.com/current/gcscd2022/class/DisplayProgramme.php on line 195
Call Stack
#TimeMemoryFunctionLocation
10.0005253272{main}( ).../schedule_sponsored.php:0
20.15001788112include( '/var/www/interactive-programme.europa-organisation.com/current/gcscd2022/view/content.php' ).../schedule_sponsored.php:88
30.15701803824DisplayProgramme::getPersonsInfoWithMedia( ).../content.php:585

Leon TSHILOLO (CONGO, THE DEMOCRATIC REPUBLIC OF THE), Dipty JAIN (INDIA)

Amphitheatre AB
16/06
13:00 - 14:00
Sponsored session
13:00 - 13:20
What therapeutic strategy in 2022 for sickle cell disease in Africa

Leon TSHILOLO (CONGO, THE DEMOCRATIC REPUBLIC OF THE)

13:20 - 13:40
What therapeutic strategy in 2022 for sickle cell disease in USA

Russell WARE (UNITED STATES)

13:40 - 14:00
What therapeutic strategy in 2022 for sickle cell disease in Europe

Bérengère KOEHL (FRANCE)

Amphitheatre AB
16/06
17:55 - 18:35
Sponsored session

Chair: Julie KANTER WASHKO (UNITED STATES)  

17:55 - 18:00
Welcome and introductions

Julie KANTER WASHKO (UNITED STATES)

18:00 - 18:08
A clinical case from Ghana – treatment approaches and complication management

Yvonne DEI-ADOMAKOH (GHANA)

18:08 - 18:18
Health disparities in Sickle Cell Disease – what can we learn from each other?

Lucia DE FRANCESCHI (ITALY)

18:18 - 18:28
Looking ahead: how will novel therapies change our approach to clinical management?

Julie KANTER WASHKO (UNITED STATES)

18:28 - 18:35
Q&A - Panel discussion

Amphitheatre AB
17/06
12:30 - 13:30
Sponsored session

Chair: Nirmish SHAH (UNITED STATES)  

12:35 - 12:50
HbS polymerization as a driver of disease pathology and progression in SCD

Caterina MINNITI (UNITED STATES)

12:50 - 13:05
Evidence for targeting HbS polymerization as a clinical paradigm shift

Miguel ABBOUD (LEBANON)

13:05 - 13:20
Real-world clinical experience with targeting HbS polymerization: perspectives from the United States

Nirmish SHAH (UNITED STATES)

13:20 - 13:30
Discussion

*Access allowed only to HCPs

Amphitheatre AB
17/06
17:45 - 18:45
Sponsored session

Chair: Aicha BAH (FRANCE)  

17:45 - 18:05
The advantages and optimizations of automatic red blood cell exchange to treat Sickle Cell Desease

Olivier HECQUET (FRANCE)

18:05 - 18:25
The Role of apheresis in a comprehensive Sickle Cell Service

Dimitris TSITSIKAS (UNITED KINGDOM)

18:25 - 18:45
Tailoring Apheresis Cell Therapy Collections for Sickle Cell Disease

John MANIS (UNITED STATES)